Super enhancers in cancers, complex disease, and developmental disorders

Genes

Volumn 6, Issue 4, 2015, Pages 1183-1200

  Niederriter, Adrienne R ^a   Varshney, Arushi ^a   Parker, Stephen C J ^a   Martin, Donna M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Complex disease; Developmental disorder; Stretch enhancer; Super enhancer; Transcription

Indexed keywords

4 (4 CHLOROPHENYL) 2,3,9 TRIMETHYL 6H THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE 6 ACETIC ACID TERT BUTYL ESTER; BROMODOMAIN INHIBITOR; COHESIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE; I BET; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEDIATOR COMPLEX; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN KINASE INHIBITOR; THZ 1; TOFACITINIB; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DEVELOPMENTAL DISORDER; DRUG MECHANISM; DRUG TARGETING; ENHANCER REGION; GENE CONTROL; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MENDELIAN DISEASE; MOLECULAR PATHOLOGY; MULTIPLE MYELOMA; NEOPLASM; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PROTEIN DNA BINDING; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SUPER ENHANCER; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION;

EID: 84947061003     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes6041183     Document Type: Review

References (41)

1. Banerji, J.; Rusconi, S.; Schaffner, W. Expression of a β-globin gene is enhanced by remote SV40 DNA sequences. Cell 1981, 27, 299-308.
2. Whyte, W.A.; Orlando, D.A.; Hnisz, D.; Abraham, B.J.; Lin, C.Y.; Kagey, M.H.; Rahl, P.B.; Lee, T.I.; Young, R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153, 307-319.
3. Loven, J.; Hoke, H.A.; Lin, C.Y.; Lau, A.; Orlando, D.A.; Vakoc, C.R.; Bradner, J.E.; Lee, T.I.; Young, R.A. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013, 153, 320-334.
4. Sanyal, A.; Lajoie, B.R.; Jain, G.; Dekker, J. The long-range interaction landscape of gene promoters. Nature 2012, 489, 109-113.
5. Pott, S.; Lieb, J.D. What are super-enhancers? Nat. Genet. 2015, 47, 8-12.
6. Song, L.; Zhang, Z.; Grasfeder, L.L.; Boyle, A.P.; Giresi, P.G.; Lee, B.K.; Sheffield, N.C.; Graf, S.; Huss, M.; Keefe, D.; et al. Open chromatin defined by DNasei and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 2011, 21, 1757-1767.
7. Gaulton, K.J.; Nammo, T.; Pasquali, L.; Simon, J.M.; Giresi, P.G.; Fogarty, M.P.; Panhuis, T.M.; Mieczkowski, P.; Secchi, A.; Bosco, D.; et al. A map of open chromatin in human pancreatic islets. Nat. Genet. 2010, 42, 255-259.
8. Hnisz, D.; Schuijers, J.; Lin, C.Y.; Weintraub, A.S.; Abraham, B.J.; Lee, T.I.; Bradner, J.E.; Young, R.A. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol. Cell 2015, 58, 362-370.
9. Dawson, M.A.; Gudgin, E.J.; Horton, S.J.; Giotopoulos, G.; Meduri, E.; Robson, S.; Cannizzaro, E.; Osaki, H.; Wiese, M.; Putwain, S.; et al. Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia. Leukemia 2014, 28, 311-320.
10. Hnisz, D.; Abraham, B.J.; Lee, T.I.; Lau, A.; Saint-Andre, V.; Sigova, A.A.; Hoke, H.A.; Young, R.A. Super-enhancers in the control of cell identity and disease. Cell 2013, 155, 934-947.
11. Zhou, H.; Schmidt, S.C.; Jiang, S.; Willox, B.; Bernhardt, K.; Liang, J.; Johannsen, E.C.; Kharchenko, P.; Gewurz, B.E.; Kieff, E.; et al. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe 2015, 17, 205-216.
12. Groschel, S.; Sanders, M.A.; Hoogenboezem, R.; de Wit, E.; Bouwman, B.A.; Erpelinck, C.; van der Velden, V.H.; Havermans, M.; Avellino, R.; van Lom, K.; et al. A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 2014, 157, 369-381.
13. Northcott, P.A.; Lee, C.; Zichner, T.; Stutz, A.M.; Erkek, S.; Kawauchi, D.; Shih, D.J.; Hovestadt, V.; Zapatka, M.; Sturm, D.; et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 2014, 511, 428-434.
14. Chipumuro, E.; Marco, E.; Christensen, C.L.; Kwiatkowski, N.; Zhang, T.; Hatheway, C.M.; Abraham, B.J.; Sharma, B.; Yeung, C.; Altabef, A.; et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell 2014, 159, 1126-1139.
15. Vahedi, G.; Kanno, Y.; Furumoto, Y.; Jiang, K.; Parker, S.C.; Erdos, M.R.; Davis, S.R.; Roychoudhuri, R.; Restifo, N.P.; Gadina, M.; et al. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 2015, 520, 558-562.
16. Achour, M.; le Gras, S.; Keime, C.; Parmentier, F.; Lejeune, F.X.; Boutillier, A.L.; Neri, C.; Davidson, I.; Merienne, K. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of huntington's disease mice. Hum. Mol. Genet. 2015, 24, 3481-3496.
17. Chapuy, B.; McKeown, M.R.; Lin, C.Y.; Monti, S.; Roemer, M.G.; Qi, J.; Rahl, P.B.; Sun, H.H.; Yeda, K.T.; Doench, J.G.; et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 2013, 24, 777-790.
18. Brown, J.D.; Lin, C.Y.; Duan, Q.; Griffin, G.; Federation, A.J.; Paranal, R.M.; Bair, S.; Newton, G.; Lichtman, A.H.; Kung, A.L.; et al. Nf-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol. Cell 2014, 56, 219-231.
19. Creyghton, M.P.; Cheng, A.W.; Welstead, G.G.; Kooistra, T.; Carey, B.W.; Steine, E.J.; Hanna, J.; Lodato, M.A.; Frampton, G.M.; Sharp, P.A.; et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 2010, 107, 21931-21936.
20. Parker, S.C.; Stitzel, M.L.; Taylor, D.L.; Orozco, J.M.; Erdos, M.R.; Akiyama, J.A.; van Bueren, K.L.; Chines, P.S.; Narisu, N.; Black, B.L.; et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. USA 2013, 110, 17921-17926.
21. Ernst, J.; Kellis, M. Chromhmm: Automating chromatin-state discovery and characterization. Nat. Methods 2012, 9, 215-216.
22. Ernst, J.; Kheradpour, P.; Mikkelsen, T.S.; Shoresh, N.; Ward, L.D.; Epstein, C.B.; Zhang, X.; Wang, L.; Issner, R.; Coyne, M.; et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473, 43-49.
23. Quang, D.X.; Erdos, M.R.; Parker, S.C.; Collins, F.S. Motif signatures in stretch enhancers are enriched for disease-associated genetic variants. Epigenet. Chromatin 2015, 8, doi:10.1186/ s13072-015-0015-7.
24. Dowen, J.M.; Fan, Z.P.; Hnisz, D.; Ren, G.; Abraham, B.J.; Zhang, L.N.; Weintraub, A.S.; Schuijers, J.; Lee, T.I.; Zhao, K.; et al. Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell 2014, 159, 374-387.
25. Yin, J.W.; Wang, G. The mediator complex: A master coordinator of transcription and cell lineage development. Development 2014, 141, 977-987.
26. Kagey, M.H.; Newman, J.J.; Bilodeau, S.; Zhan, Y.; Orlando, D.A.; van Berkum, N.L.; Ebmeier, C.C.; Goossens, J.; Rahl, P.B.; Levine, S.S.; et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature 2010, 467, 430-435.
27. Herranz, D.; Ambesi-Impiombato, A.; Palomero, T.; Schnell, S.A.; Belver, L.; Wendorff, A.A.; Xu, L.; Castillo-Martin, M.; Llobet-Navas, D.; Cordon-Cardo, C.; et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat. Med. 2014, 20, 1130-1137.
28. Lee, T.I.; Young, R.A. Transcriptional regulation and its misregulation in disease. Cell 2013, 152, 1237-1251.
29. Izumi, K.; Nakato, R.; Zhang, Z.; Edmondson, A.C.; Noon, S.; Dulik, M.C.; Rajagopalan, R.; Venditti, C.P.; Gripp, K.; Samanich, J.; et al. Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin. Nat. Genet. 2015, 47, 338-344.
30. Vissers, L.E.; van Ravenswaaij, C.M.; Admiraal, R.; Hurst, J.A.; de Vries, B.B.; Janssen, I.M.; van der Vliet, W.A.; Huys, E.H.; de Jong, P.J.; Hamel, B.C.; et al. Mutations in a new member of the chromodomain gene family cause charge syndrome. Nat. Genet. 2004, 36, 955-957.
31. Schnetz, M.P.; Handoko, L.; Akhtar-Zaidi, B.; Bartels, C.F.; Pereira, C.F.; Fisher, A.G.; Adams, D.J.; Flicek, P.; Crawford, G.E.; Laframboise, T.; et al. CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet. 2010, 6, e1001023.
32. Schnetz, M.P.; Bartels, C.F.; Shastri, K.; Balasubramanian, D.; Zentner, G.E.; Balaji, R.; Zhang, X.; Song, L.; Wang, Z.; Laframboise, T.; et al. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res. 2009, 19, 590-601.
33. Petrij, F.; Giles, R.H.; Dauwerse, H.G.; Saris, J.J.; Hennekam, R.C.; Masuno, M.; Tommerup, N.; van Ommen, G.J.; Goodman, R.H.; Peters, D.J.; et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995, 376, 348-351.
34. Feng, W.; Khan, M.A.; Bellvis, P.; Zhu, Z.; Bernhardt, O.; Herold-Mende, C.; Liu, H.K. The chromatin remodeler CHD7 regulates adult neurogenesis via activation of SoxC transcription factors. Cell Stem Cell 2013, 13, 62-72.
35. Lopez, A.J.; Wood, M.A. Role of nucleosome remodeling in neurodevelopmental and intellectual disability disorders. Front. Behav. Neurosci. 2015, 9, doi:10.3389/fnbeh.2015.00100.
36. Delmore, J.E.; Issa, G.C.; Lemieux, M.E.; Rahl, P.B.; Shi, J.; Jacobs, H.M.; Kastritis, E.; Gilpatrick, T.; Paranal, R.M.; Qi, J.; et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011, 146, 904-917.
37. Affer, M.; Chesi, M.; Chen, W.D.; Keats, J.J.; Demchenko, Y.N.; Tamizhmani, K.; Garbitt, V.M.; Riggs, D.L.; Brents, L.A.; Roschke, A.V.; et al. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia 2014, 28, 1725-1735.
38. Mansour, M.R.; Abraham, B.J.; Anders, L.; Berezovskaya, A.; Gutierrez, A.; Durbin, A.D.; Etchin, J.; Lawton, L.; Sallan, S.E.; Silverman, L.B.; et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 2014, 346, 1373-1377.
39. National Cancer Institute. Available online: www.cancer.gov/types/childhood-cancers (accessed on 30 October 2015).
40. Puente, X.S.; Bea, S.; Valdes-Mas, R.; Villamor, N.; Gutierrez-Abril, J.; Martin-Subero, J.I.; Munar, M.; Rubio-Perez, C.; Jares, P.; Aymerich, M.; et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 2015, 526, 519-524.
41. Garriga, J.; Grana, X. Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene 2004, 337, 15-23.